US Markets
1 153A.T Peers
Competitors of 153A.T are showing a mixed session today, with cybersecurity names catching a bid while identity verification and Asian tech peers face pressure. Qualys is the standout mover, surging +4.55% to $89.60 on elevated volume of over 1.16 million shares, continuing a multi-day rebound that has seen the stock claw back ground toward its $90 intraday high. The rally comes despite a William Blair downgrade to Market Perform over AI disruption concerns in the vulnerability management space — investors appear to be looking past the analyst cut, buoyed by spillover optimism from strong AI-driven earnings at Microsoft and Amazon and a broader tech sector rebound. Attention is now turning to Qualys's Q1 2026 earnings on May 5, with analysts expecting $1.81 EPS on $173.7M in revenue, though the stock remains well off its 52-week high of $155.47, highlighting lingering valuation uncertainty. Mitek Systems slipped -3.20% to $13.61, weighed by COO Garrett Gafke's $2.12 million insider stock sale and broader software sector headwinds, even as a new integration partnership with Tyfone for its Check Fraud Defender platform offers a fundamental positive; the stock trades near the upper end of its year range ( 52-week high: $15.80), with a consensus Hold and $16 price target. On the Asian side, GMO Financial Gate dropped -3.83% to ¥1,907, while 6227.TWO fell -2.56% and Henka edged down -1.14%, suggesting persistent sector-wide softness in Japanese and Taiwanese tech.
Analyzing list...
Notable Price Movement
Lithium Americas
Lithium Americas surged over 16% on heavy volume — nearly 3x the daily average — as the Thacker Pass project narrative gains momentum, with Phase 1 construction visibly advancing, workforce ramping toward 1,800 workers, and the company positioned as a U.S. national security critical minerals asset backed by a $2.23B DOE loan and $650M GM equity investment. Analysts remain split: Jefferies and Wedbush hold $8 price targets (39% upside from current levels), while HSBC and Scotiabank sit at $4.50–$5, citing 15% capex inflation and dilution risk from at-the-market offerings; Wall Street consensus sits at a 'Moderate Buy' with a ~$6.10 mean target.